Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Smith

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
The British Journal of Dermatology|March 30, 2026
Circulating metabolites associated with psoriasis in the UK Biobank and the HUNT Study: A cross-sectional study of 470,352 participantsAlya G A Arham, Abhibhav Sharma, Laurent F Thomas, et al.
Human Genomics|November 27, 2022
The integration of large-scale public data and network analysis uncovers molecular characteristics of psoriasisAntonio Federico, Alisa Pavel, Lena Möbus, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2002
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitisSakari Reitamo, Edwin J M Van Leent, Vincent Ho, et al.
Therapeutic Advances in Musculoskeletal Disease|April 3, 2026
Definition of the terms used to describe psoriatic disease datasets: a HIPPOCRATES initiativeOliver FitzGerald, Catherine Smith, Christine Huppertz, et al.
The Journal of Investigative Dermatology|August 22, 2018
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort StudyNina Wilkinson, Teresa Tsakok, Nick Dand, et al.
Blood Advances|March 19, 2024
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemiaMark Levis, Alexander Perl, Gary Schiller, et al.
BMJ Open|February 24, 2022
Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trialIsabelle L Smith, Rachael Gilberts, Sarah Brown, et al.
Rheumatology (Oxford, England)|May 31, 2022
Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDsLaura Tucker, Alexander Allen, David Chandler, et al.
Rheumatology (Oxford, England)|May 31, 2022
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDsLaura Tucker, Alexander Allen, David Chandler, et al.
Rheumatology (Oxford, England)|October 24, 2020
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeWilliam Tillett, Alexander Allen, Laura Tucker, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
The British Journal of Dermatology|March 30, 2026
Circulating metabolites associated with psoriasis in the UK Biobank and the HUNT Study: A cross-sectional study of 470,352 participantsAlya G A Arham, Abhibhav Sharma, Laurent F Thomas, et al.
Human Genomics|November 27, 2022
The integration of large-scale public data and network analysis uncovers molecular characteristics of psoriasisAntonio Federico, Alisa Pavel, Lena Möbus, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2002
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitisSakari Reitamo, Edwin J M Van Leent, Vincent Ho, et al.
Therapeutic Advances in Musculoskeletal Disease|April 3, 2026
Definition of the terms used to describe psoriatic disease datasets: a HIPPOCRATES initiativeOliver FitzGerald, Catherine Smith, Christine Huppertz, et al.
The Journal of Investigative Dermatology|August 22, 2018
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort StudyNina Wilkinson, Teresa Tsakok, Nick Dand, et al.
Blood Advances|March 19, 2024
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemiaMark Levis, Alexander Perl, Gary Schiller, et al.
BMJ Open|February 24, 2022
Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trialIsabelle L Smith, Rachael Gilberts, Sarah Brown, et al.
Rheumatology (Oxford, England)|May 31, 2022
Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDsLaura Tucker, Alexander Allen, David Chandler, et al.
Rheumatology (Oxford, England)|May 31, 2022
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDsLaura Tucker, Alexander Allen, David Chandler, et al.
Rheumatology (Oxford, England)|October 24, 2020
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeWilliam Tillett, Alexander Allen, Laura Tucker, et al.
Pageof 19